Accelerating the development of effective therapeutics for plexiform and cutaneous neurofibromas
Baltimore, Maryland
Joined May 2023
- Tweets114
- Following103
- Followers177
- Likes110
Interested in becoming the next Francis S. Collins Scholar? Join us for an upcoming Information Session with Dr. Jaishri Blakeley.
Wednesday, September 23, 2026
11:00 AM ET
We look forward to meeting the next generation of NF1 research leaders!
#EndNF #NFResearch
ALT QR Code to Register for FCS Informational Webinar, Sept 23, 2026
From discovery to clinical trials, NTAP investigators are advancing NF1 therapeutics and bringing us closer to a cure. Thank you to the Children's Tumor Foundation for bringing the NF community together to share science, spark collaboration, & accelerate progress. #NFConference
Neurofibromatosis Therapeutic Acceleration Program retweeted
Venture capital is in the room at the NF Conference. We've brought NF innovators and biotech investors together to pressure-test emerging programs on science, strategy, and the path to funding. Faster capital = faster treatments. #EndNF #NFConference
Neurofibromatosis Therapeutic Acceleration Program retweeted
In case you missed it, our December newsletter is packed with highlights from 2025.
- Check out exciting innovations
- Learn about upcoming events and resources
- Discover how we’re driving impact through entrepreneurship and tech commercialization
buff.ly/KjiENf6
A powerful opportunity to advance innovative therapies and repurpose treatments — accelerating discoveries that can translate into real impact for patients. #EndNF #NFResearch #RareDisease #Innovation
🚨 Application for the 2025 Drug Discovery Initiative is OPEN! NF researchers, this is your chance to advance innovative therapies and repurposed treatments or validate new NF targets. Deadline: February 2, 2026 by 4 PM EST
🔗 Apply now: go.ctf.org/ddi
#EndNF
NTAP is proud to support @VasuLabUCSF and team's research published in @JCI_insight "Tumor heterogeneity underlies clinical outcome and MEK inhibitor response in somatic NF1-mutant glioblastoma" #EndNF #NFResearch
NF1 is frequently mutated in #glioblastoma, yet therapies targeting this alteration often fall short.
@VasuLabUCSF & team @UCSF now show NF1 mutant glioblastomas exhibit prognostic signatures with distinct sensitivity to MEK inhibition: insight.jci.org/articles/vie…
A powerful tribute to Dr. Verena Staedtke’s vision. Huge congratulations to Dr. Bai, @jblakel3, and the NTAP/JH/KKI teams for this exciting step forward. Grateful for the progress — and hopeful for what’s ahead. #EndNF #NFResearch
Honoring Verena Staedtke’s vision, @JohnsHopkins researchers, led by Renyuan Bai w/ support from Jaishri Blakeley at @ntapresearch, are advancing gene therapy for NF1. An AAV vector delivering neurofibromin shows promise + hope for patients. buff.ly/R4pRpoD
A major milestone for the NF1 community. Congratulations to all involved. Here's to continued momentum in NF research and drug development! #EndNF #NFResearch
This Post is from an account that no longer exists. Learn more
NF1 Researcher? NTAP launched a Scholars program to support early-career PhD-level scientists.
LOIs are due on October 20th. Apply today!
1 day way!
Join us tomorrow at 10AM for the Francis Collins Scholars Information session.
Are you an early-career clinician-scientist? Ready to make an impact on NF1 research? Join us for an information session on the Francis Collins Scholars Program.
Wednesday, October 1, 2025 @ 10 AM EST
🔗 Register here: forms.office.com/r/nGqDFnN2B…
#Research #EndNF #NF1
Are you an early-career clinician-scientist? Ready to make an impact on NF1 research? Join us for an information session on the Francis Collins Scholars Program.
Wednesday, October 1, 2025 @ 10 AM EST
🔗 Register here: forms.office.com/r/nGqDFnN2B…
#Research #EndNF #NF1
Neurofibromatosis Therapeutic Acceleration Program retweeted
Fueling the next wave of NF research: Nearly $1.5M in Young Investigator Awards will drive cutting-edge science, smarter care & real solutions for NF1, NF2-SWN & SWN. Meet the early-career scientists shaping NF’s future: ctf.org/news/yia2025/
Neurofibromatosis Therapeutic Acceleration Program retweeted
App open thru 9/8! Junior faculty, fellows, postdocs & PhD students in #NFresearch—apply now for the NFYIF: a career-catalyzing event for mentorship, productivity & community
info.ceconcepts.com/nfyif-00…
#EndNF #Neurofibromatosis #YoungInvestigators #PostdocLife #PhDlife #ceconcepts
Incredible time for the Francis Collins Scholars community! Our 7 summer interns shared powerful NF1 research on MPNST, optic gliomas, GI symptoms & neuropsychiatric profiles. Huge thanks to mentors & supporters! #FrancisCollinsScholars #NFResearch
🚨Updated Criteria!
NTAP @HopkinsMedicine is funding early-career PhD (or equivalent) scientists focused on NF1 🧬
Learn more: NF1 Laboratory Scholars Program—mentorship, salary + project support! 🔗n-tap.org/who-we-are/news/ne…
· LOI due: Oct 20, 2025
#EndNF
🚨 Just 20 days left! 🚨
Apply by Aug 13 for up to $50K from the DHART SPORE DRP & CEP Awards to support NF1 & Rasopathy research. Open to clinical, population & basic science investigators.
🔗 dhartspore.org/about/develop…
#NF1 #ResearchFunding #DHARTSPORE
🚨 Double the funding, double the chance! Apply now for the DHART SPORE Developmental Research Program (DRP) & Career Enhancement Program (CEP) Awards. Don’t miss out!
🔗 Apply here: indianactsi.org/funding/oppo…
🗓️ Deadline: August 13, 2025
Neurofibromatosis Therapeutic Acceleration Program retweeted
The cancer center’s D. Wade Clapp, MD, and colleagues have published their latest findings in the Journal of Neuro-Oncology. Learn more: ow.ly/elPY50Win4s. #ResearchCuresCancer #NCIcomprehensive @JNeurooncol
Neurofibromatosis Therapeutic Acceleration Program retweeted
We're excited to have @BettegowdaMDPHD from @HopkinsNsurg join us this week for our #Neurosurgery Grand Rounds!
